Sacrococcygeal teratoma laboratory tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
| Line 26: | Line 26: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Orthopedics]] | |||
Revision as of 15:26, 27 November 2017
|
Sacrococcygeal teratoma Microchapters |
|
Diagnosis |
|---|
| Echocardiography and Ultrasound |
|
Treatment |
|
Case Studies |
|
Sacrococcygeal teratoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Sacrococcygeal teratoma laboratory tests |
|
Risk calculators and risk factors for Sacrococcygeal teratoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
Overview
Alpha-fetoprotein and beta-hCG should be evaluated in patients with sacrococcygeal teratoma to determine the presence of malignant component of the tumor.[1]